Overview
- Bloom reported a blowout Q1 with $751.1 million in revenue and raised full-year 2026 guidance to $3.4–$3.8 billion while boosting non‑GAAP EPS targets, a performance that helped fuel a rapid share rally.
- The stock peaked in late June then dropped sharply on June 23, with traders citing profit-taking and fresh doubts about whether the company can meet the high expectations priced into its market cap.
- About $373.3 million of Q1 revenue came from related‑party sales to Brookfield joint ventures, highlighting that a large slice of early revenue depends on a single infrastructure partner.
- Analysts have tempered enthusiasm: Bernstein started coverage with a Market Perform and a $276 target while calling for clearer plans for production capacity and a sustainable free‑cash‑flow path.
- Investors face execution and concentration risks because converting the roughly $20 billion backlog into steady revenue requires faster Fremont manufacturing scale‑up, timely site hookups and stable tax or incentive support, and insider sales have added governance scrutiny.